What is Leerink Partnrs' Forecast for Quanterix Q2 Earnings?

Quanterix Co. (NASDAQ:QTRX - Free Report) - Analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for Quanterix in a research note issued on Monday, May 12th. Leerink Partnrs analyst P. Souda now forecasts that the company will earn ($0.45) per share for the quarter, down from their prior estimate of ($0.38). Leerink Partnrs currently has a "Hold" rating on the stock. The consensus estimate for Quanterix's current full-year earnings is ($0.98) per share. Leerink Partnrs also issued estimates for Quanterix's Q3 2025 earnings at ($0.48) EPS, Q4 2025 earnings at ($0.18) EPS, FY2025 earnings at ($1.63) EPS, Q1 2026 earnings at ($0.27) EPS, Q2 2026 earnings at ($0.26) EPS, Q3 2026 earnings at ($0.19) EPS, Q4 2026 earnings at ($0.15) EPS and FY2026 earnings at ($0.88) EPS.

A number of other analysts have also recently commented on the stock. Canaccord Genuity Group lowered their target price on shares of Quanterix from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Tuesday. Scotiabank reaffirmed an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th. Finally, Leerink Partners reiterated a "market perform" rating and set a $8.00 price objective (down from $12.00) on shares of Quanterix in a research note on Wednesday, April 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $15.60.

Quanterix Stock Down 7.8%

QTRX opened at $4.28 on Thursday. The company has a market cap of $166.02 million, a P/E ratio of -4.04 and a beta of 1.12. The firm's 50-day moving average price is $5.99 and its 200-day moving average price is $8.95. Quanterix has a 52-week low of $4.05 and a 52-week high of $19.18.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.69) by $0.16. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. The firm had revenue of $30.33 million for the quarter, compared to the consensus estimate of $28.27 million.

Institutional Investors Weigh In On Quanterix

A number of large investors have recently bought and sold shares of QTRX. Barclays PLC raised its position in Quanterix by 42.3% during the 3rd quarter. Barclays PLC now owns 146,248 shares of the company's stock worth $1,896,000 after buying an additional 43,447 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Quanterix by 28.1% during the third quarter. JPMorgan Chase & Co. now owns 217,957 shares of the company's stock worth $2,825,000 after purchasing an additional 47,873 shares during the last quarter. Tallon Kerry Patrick purchased a new position in shares of Quanterix during the fourth quarter worth $169,000. Janney Capital Management LLC lifted its position in Quanterix by 40.9% during the fourth quarter. Janney Capital Management LLC now owns 33,192 shares of the company's stock valued at $353,000 after purchasing an additional 9,639 shares during the period. Finally, abrdn plc boosted its holdings in Quanterix by 24.4% in the fourth quarter. abrdn plc now owns 206,923 shares of the company's stock valued at $2,200,000 after purchasing an additional 40,525 shares during the last quarter. Hedge funds and other institutional investors own 86.48% of the company's stock.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.